SlideShare a Scribd company logo
1 of 48
Diabetic
Emergencies
Objectives
General Objective:
• Identify the common diabetic complications in an
  emergency setting.

Specific Objective:
• Describe diabetic ketoacidosis, hyperosmolar
  syndrome, and hypoglycemia.
• Describe their diagnosis, treatment, and prevention.
Introduction
• People with diabetes suffer from diabetic
  complications that may arise due to erratic blood
  sugar levels, missed meals, accidental overdose of
  medications, or too much strenuous exercise. These
  things could affect the sensitive body of a person
  with diabetes and could lead to
  serious incidences of hypoglycemia or
  hyperglycemia.
Introduction
• Uncontrolled blood sugar often contributes to the
  incidence of diabetic emergencies and
  complications. Individuals who experience blood
  sugar levels that are too high or low for prolonged
  periods of time may develop conditions that could
  lead to a coma.
• Hypoglycemia results from excessively low blood
  sugar levels caused by either insufficient food
  consumption or the presence of too much insulin.
Introduction
• Diabetic ketoacidosis is a condition that occurs due
  to an absence or insufficient supply of insulin, which
  forces the body to burn fat and creates ketones that
  subsequently accumulate in the body.
• Hyperosmolar syndrome is a diabetic condition that
  results from excessively high blood sugar levels,
  which cause the blood to adopt a thick consistency.
Hypoglycemia
• Hypoglycemia or low blood glucose is a
  clinical state associated with <55mg/dl or low
  plasma glucose with typical symptoms.




                              The Journal of Clinical
                       Endocrinology & Metabolism
                    March 1, 2009 vol. 94 no. 3 709-
Whipples triad
 Symptoms consistent with hypoglycemia
 Low plasma glucose concentration
 Relief of those symptoms after the plasma
  glucose level is raised




                             The Journal of Clinical
                      Endocrinology & Metabolism
                   March 1, 2009 vol. 94 no. 3 709-
Physiological responses




    The Journal of Clinical Endocrinology & Metabolism March
Risk factors
 insulin doses are excessive, ill-timed, or of the wrong
  type
 influx of exogenous glucose 
 insulin-independent glucose utilization 
 sensitivity to insulin 
 endogenous glucose production 
 insulin clearance 
                                  The Journal of Clinical
                           Endocrinology & Metabolism
                        March 1, 2009 vol. 94 no. 3 709-
Clinical features
MILD HYPOGLYCEMIA
- mainly adrenergic or cholinergic symptoms
 Pallor
 Diaphoresis
 Tachycardia
 Palpitations
 Hunger
 Paresthesias                    The Journal of Clinical
                            Endocrinology & Metabolism
                        March 1, 2009 vol. 94 no. 3 709-
Clinical features
MODERATE HYPOGLYCEMIA (<40 mg/dL)
- mainly neuroglycopenic symptoms
 Inability to concentrate          Confusion
 Slurred speech             Irrational behaviour
 Slower reaction time       Blurred vision
 Somnolence                 Extreme fatigue


                                 The Journal of Clinical
                          Endocrinology & Metabolism
                       March 1, 2009 vol. 94 no. 3 709-
Clinical features
SEVERE HYPOGLYCEMIA (<20 mg/dL )
 Associated with severe impairment of neurologic
  function
 Completely disoriented behavior
 LOC
 Coma
 Seizures
                                The Journal of Clinical
                         Endocrinology & Metabolism
                      March 1, 2009 vol. 94 no. 3 709-
Treatment
MILD HYPOGLYCEMIA
 Oral carbohydrates (at least 15gm)
 Sources include
     • Three glucose tablets (5g each)
     • 2 ½ cups of fruit juice
     • ½ to ¾ cup regular soda
     • 1 cup of milk
 If patient is unable to take orallyThe Journal of Clinical
                                      give IV dextrose
                               Endocrinology & Metabolism
                           March 1, 2009 vol. 94 no. 3 709-
Treatment
MODERATE TO SEVERE HYPOGLYCEMIA
 Dextrose - 50mL of 50% dextrose IV bolus after
  blood draw followed by 10% dextrose
 Glucagon – 1mg IM or SC can be given
 Effective in treating hypoglycemia only if sufficient
  liver glycogen present
 These measures raise blood glucose only transiently
 Patient is urged to eat as soon as possible
                                   The Journal of Clinical
                            Endocrinology & Metabolism
                         March 1, 2009 vol. 94 no. 3 709-
Prevention
 Patient education
 Knowing signs and symptoms of hypoglycemia
 Take meals on a regular schedule
 Carry a source of carbohydrate
 Self monitoring of blood glucose
 Take regular insulin at least 30 min before eating


                                 The Journal of Clinical
                          Endocrinology & Metabolism
                       March 1, 2009 vol. 94 no. 3 709-
Diabetic Ketoacidosis
 Acute, major, life-threatening complication of
  diabetes
 Increase in the serum concentration of ketones
 Blood glucose level of greater than 250 mg/dL
 Blood pH of less than 7.2
 Bicarbonate level of 18 mEq/L or less


        Joint British Diabetes Society guideline for the
        management of diabetic ketoacidosis Diabetic
    Medicine Volume 28, Issue 5, pages 508–515, May
 Incidence about 1 out of 2000
 Usually occurs in younger individuals but can occur
  in patients with diabetes at any age
 Mortality rates are around 2-5%
 No sex predilection



        Joint British Diabetes Society guideline for the
        management of diabetic ketoacidosis Diabetic
    Medicine Volume 28, Issue 5, pages 508–515, May
Mechanism
 Absolute or relative insulin deficiency
 Increased gluconeogenesis
 Elevation of counter regulatory hormones such as
  glucagon, cortisol, growth hormone, and
  catecholamines




        Joint British Diabetes Society guideline for the
        management of diabetic ketoacidosis Diabetic
    Medicine Volume 28, Issue 5, pages 508–515, May
Causes
•   Infections
•   Inadequate insulin treatment or non-compliance
•   New onset diabetes
•   Infarction
•   Drugs
•   Pregnancy


          Joint British Diabetes Society guideline for the
          management of diabetic ketoacidosis Diabetic
      Medicine Volume 28, Issue 5, pages 508–515, May
Classification
                              Moderate
                 Mild DKA                   Severe DKA
                              DKA

Plasma glucose   > 250 mg/dl > 250 mg/dl    > 250 mg/dl

Arterial ph      7.25-7.30    7.0-7.24      < 7.0
Serum
                 15-18        10-<15        < 10
bicarbonate
Urine ketones    +            +             +
Anion gap        >10          >12           >12
Alteration in
           Joint British Diabetes Society guideline for the
                  alert        Alert/drowsy stupor/coma
sensorium
        management of diabetic ketoacidosis Diabetic
    Medicine Volume 28, Issue 5, pages 508–515, May
Clinical presentations
•   Nausea/vomiting                  Thirst/polyuria
•   Abdominal pain              Shortness of breath
•   Generalized weakness             Malaise/lethargy
•   Confusional state
•   Fever, dysuria, coughing
•   Chest pain
•   Palpitations
          Joint British Diabetes Society guideline for the
          management of diabetic ketoacidosis Diabetic
      Medicine Volume 28, Issue 5, pages 508–515, May
Physical findings
 Tachycardia
 Signs of dehydration - weak and rapid pulse, dry
  tongue and skin, hypotension, and increased
  capillary refill time
 Tachypnea/ respiratory distress
 Acetone odor in breath
 Abdominal tenderness
 Lethargy/ obtundation/ cerebral edema/ possibly
  coma Joint British Diabetes Society guideline for the
           management of diabetic ketoacidosis Diabetic
 Fever/ Hypothermia 28, Issue 5, pages 508–515, May
     Medicine Volume
Laboratory findings
 Hyperglycemia >250mg/dL
 Serum ketones +
 ABG:
   metabolic acidosis
   low bicarbonate
   low pH (<7.2)
       Joint British Diabetes Society guideline for the
       management of diabetic ketoacidosis Diabetic
   Medicine Volume 28, Issue 5, pages 508–515, May
Serum electrolytes
• Serum potassium may be mildly elevated despite
  total body potassium deficit
• The serum sodium level usually is low (1.6meq
  reduction in serum sodium for each 5.6mmol/L or
  100mg/dL of rise in serum glucose)
• The serum chloride and phosphorus levels are low
 The anion gap is elevated
 Plasma osmolarity usually is increased (>290
  mOsm/L).Joint British Diabetes Society guideline for the
          management of diabetic ketoacidosis Diabetic
     Medicine Volume 28, Issue 5, pages 508–515, May
Others
 Leukocytosis (even without infection)
 BUN and creatinine are frequently increased
 Hypertriglyceridemia/ Hyperlipoproteinemia
 Serum assays for β hydroxybutrate more accurately
  reflects the true ketone body level
• ECG – for detection of hypokalemia/ hyperkalemia,
   myocardial infarction (silent MI in diabetics)

        Joint British Diabetes Society guideline for the
        management of diabetic ketoacidosis Diabetic
    Medicine Volume 28, Issue 5, pages 508–515, May
Differential diagnosis
LACTIC ACIDOSIS
 most common cause of metabolic acidosis in
  hospitalized patients
 presentation is identical to DKA
 serum glucose and ketones should be normal
 serum lactate concentration should be greater than
  5mm
 therapy is directed at the underlying cause and
  optimizing tissue perfusion Society guideline for the
          Joint British Diabetes
          management of diabetic ketoacidosis Diabetic
     Medicine Volume 28, Issue 5, pages 508–515, May
Differential diagnosis
STARVATION KETOSIS
 due to inadequate carbohydrate availability, resulting
  in lipolysis and ketone production
 blood glucose is usually normal
 blood rarely does have large amounts of ketones
 arterial pH is normal
 anion gap is at most mildly elevated
        Joint British Diabetes Society guideline for the
        management of diabetic ketoacidosis Diabetic
    Medicine Volume 28, Issue 5, pages 508–515, May
Differential diagnosis
ALCOHOLIC KETOACIDOSIS
• anion gap is elevated
• serum and urine ketones are present
• alcoholic ketoacidosis produces an even higher ratio
  of β-hydroxybutyrate to acetoacetate than DKA does
• usually, patient is normoglycemic or hypoglycemic


        Joint British Diabetes Society guideline for the
        management of diabetic ketoacidosis Diabetic
    Medicine Volume 28, Issue 5, pages 508–515, May
Differential diagnosis
UREMIC ACIDOSIS
 Extremely large elevations in the BUN (>200 mg/dL)
  and creatinine (>10 mg/dL) with normoglycemia
 pH and anion gap are usually only mildly abnormal
 treatment is supportive, with careful attention to fluid
  and electrolytes until dialysis can be performed


        Joint British Diabetes Society guideline for the
        management of diabetic ketoacidosis Diabetic
    Medicine Volume 28, Issue 5, pages 508–515, May
Treatment
IV FLUIDS
• 2-3L of 0.9% saline over first 1–3 h (10–15mL/kg per
  hour)
• 0.45% saline at 150-300mL/h (if hemodynamically
  stable and urine output is adequate )
• change to 5% glucose and 0.45% saline at 100–200
  mL/h when plasma glucose reaches 250mg/dL
  (14mmol/L).
          Joint British Diabetes Society guideline for the
          management of diabetic ketoacidosis Diabetic
    Medicine Volume 28, Issue 5, pages 508–515, May
Treatment
INSULIN
• if serum K+ is <3.3mmol/L, do not administer insulin
  until it is corrected to >3.3mmol/L
• bolus of IV (0.1 units/kg) or IM (0.3 units/kg) short-
  acting insulin followed by 0.1 units/kg/hr by
  continuous IV infusion
• Increase 2- to 3-fold if no response by 2–4h

        Joint British Diabetes Society guideline for the
        management of diabetic ketoacidosis Diabetic
    Medicine Volume 28, Issue 5, pages 508–515, May
Treatment
INSULIN
• IV regular insulin should be given until the acidosis
  resolves and the patient is metabolically stable
• Intermediate or long-acting insulin, in combination
  with SC short-acting insulin, should be administered
  as soon as the patient resumes eating


        Joint British Diabetes Society guideline for the
        management of diabetic ketoacidosis Diabetic
    Medicine Volume 28, Issue 5, pages 508–515, May
Treatment
MONITOR
 Blood glucose every 1–2 h;
 Serum electrolytes and anion gap every 4 h for first
  24 h.
 Blood pressure, pulse, respirations, mental
  status, fluid intake and output every 1–4 h.


        Joint British Diabetes Society guideline for the
        management of diabetic ketoacidosis Diabetic
    Medicine Volume 28, Issue 5, pages 508–515, May
Hyperosmolar
Hyperglycemic State
 The condition is characterized by
  • Hyperglycemia
  • Hyperosmolarity
  • Dehydration without significant ketoacidosis




                       10.2337/diacare.27.2007.S94
   Diabetes Care January 2004vol. 27 no. suppl 1 s94-
                                                s102
 Incidence is 1.7 case per 10000
 Mortality rate is high (10-20%) and usually due to a
  co-morbid illness
 (HHS) has a mean age of onset early in the seventh
  decade




                       10.2337/diacare.27.2007.S94
   Diabetes Care January 2004vol. 27 no. suppl 1 s94-
                                                s102
Pathophysiology
 Relative insulin deficiency and inadequate fluid
  intake
 Insulin deficiency increases hepatic glucose
  production (through glycogenolysis and
  gluconeogenesis) and impairs glucose utilization in
  skeletal muscle
 Hyperglycemia induces an osmotic diuresis that
  leads to intravascular volume depletion, which is
  exacerbated by inadequate fluid replacement
                            10.2337/diacare.27.2007.S94
 Lower levels of counterregulatory hormones and free
    Diabetes Care January 2004vol. 27 no. suppl 1 s94-
  fatty acids have been found in HHS than in DKA
                                                    s102
Clinical features
HISTORY
 Usually elderly individual, type 2 DM
 Mental confusion, lethargy, and coma
 Absence of nausea, vomiting, abdominal pain
 Frequent precipitants – pneumonia, sepsis, stroke
  MI, etc.,


                       10.2337/diacare.27.2007.S94
   Diabetes Care January 2004vol. 27 no. suppl 1 s94-
                                                s102
vs DKA




                      10.2337/diacare.27.2007.S94
  Diabetes Care January 2004vol. 27 no. suppl 1 s94-
                                               s102
Treatment
IV FLUIDS
 1–3L of 0.9% normal saline over the first 2–3 h. If the
  serum sodium >150 meq/L, 0.45% saline should be
  used.
 After hemodynamic stability is achieved, the IV fluid
  administration is directed at reversing the free water
  deficit using hypotonic fluids (0.45% saline initially
  then D5W).
 The calculated free water deficit (which averages 9–
                            10.2337/diacare.27.2007.S94
  10L) should be reversed over the next 1–2 days
    Diabetes Care January 2004vol. 27 no. suppl 1 s94-
  (infusion rates of 200–300 mL/h of hypotonic
                                                       s102
Treatment
INSULIN
• IV insulin bolus of 0.1units/kg followed by IV insulin
  at a constant infusion rate of 0.1units/kg per hour.
• If the serum glucose does not fall, increase the
  insulin infusion rate by twofold
• Glucose should be added to IV fluid when the
  plasma glucose falls to 250 mg/dL, and the insulin
  infusion rate should be decreased to 0.05–
  0.1units/kg per hour.
                            10.2337/diacare.27.2007.S94
     Diabetes Care January 2004vol. 27 no. suppl 1 s94-
                                                      s102
Treatment
INSULIN
 The insulin infusion should be continued until the
  patient has resumed eating and can be transferred
  to a SC insulin regimen
 To avoid cerebral edema the blood glucose level
  should be maintained between 250-300mg/dl until
  hyperosmolarity and mental status improve and the
  patient becomes clinically stable

                       10.2337/diacare.27.2007.S94
   Diabetes Care January 2004vol. 27 no. suppl 1 s94-
                                                s102
Treatment
POTASSIUM REPLETION
 ECG monitoring for hyperkalemia or hypokalemia
 If K+ < 5.5 give 10-20mEq/hr
 If K+ < 3.5 give 40-80mEq/hr
 Administer half as chloride and half as phosphate
  salts


                       10.2337/diacare.27.2007.S94
   Diabetes Care January 2004vol. 27 no. suppl 1 s94-
                                                s102
Monitoring
 EKG
 Vital signs
 1-2 hourly glucose
 Serum electrolytes: 2-6 hourly
 BUN and creatinine: 6-24 hourly
 Ketones: 6-24 hourly


                       10.2337/diacare.27.2007.S94
   Diabetes Care January 2004vol. 27 no. suppl 1 s94-
                                                s102
Pathogenesis of DKA and HHS:
stress, infection, or insufficient insulin. FFA, free fatty acid
Conclusion
• Diabetic emergencies are common in patients with
  diabetes, and the effects can be devastating.
  However, with continued emphasis on the timely
  and appropriate identification and management of
  diabetic emergencies, hopefully this may change.
• It is therefore important for those with diabetes to
  keep their sugar levels normal to prevent
  complications and to be able to live normal, healthy
  lives.

More Related Content

What's hot

Hyperosmolar Hyperglycaemic State
Hyperosmolar Hyperglycaemic StateHyperosmolar Hyperglycaemic State
Hyperosmolar Hyperglycaemic StateDoc Ameerul
 
Management of diabetic ketoacidosis dka
Management of diabetic ketoacidosis dkaManagement of diabetic ketoacidosis dka
Management of diabetic ketoacidosis dkasahar Hamdy
 
Management of diabetic ketoacidosis
Management of diabetic ketoacidosisManagement of diabetic ketoacidosis
Management of diabetic ketoacidosisNgọc Anh Lương
 
Diabetic coma clinical_features
Diabetic coma clinical_features Diabetic coma clinical_features
Diabetic coma clinical_features rahulverma1194
 
Hyperosmolar hyperglycaemic state
Hyperosmolar  hyperglycaemic  stateHyperosmolar  hyperglycaemic  state
Hyperosmolar hyperglycaemic stateDr. Tanmoy Roy
 
Hyperglycemic hyperosmolar
Hyperglycemic hyperosmolarHyperglycemic hyperosmolar
Hyperglycemic hyperosmolar941531003
 
Hypoglycemia
HypoglycemiaHypoglycemia
HypoglycemiaOrtiz-C
 
Status Epilepticus
Status EpilepticusStatus Epilepticus
Status EpilepticusZeeshan Khan
 
DIABETES MELLITUS and surgeon
DIABETES MELLITUS and surgeonDIABETES MELLITUS and surgeon
DIABETES MELLITUS and surgeonVikas Kumar
 
Diabetic ketoacidosis by dr. noman
Diabetic ketoacidosis by dr. nomanDiabetic ketoacidosis by dr. noman
Diabetic ketoacidosis by dr. nomanAbdullah Al Noman
 
Hyperkalemia 160108171542
Hyperkalemia 160108171542Hyperkalemia 160108171542
Hyperkalemia 160108171542Indhu Reddy
 
Diabetes ketoacidosis
Diabetes ketoacidosisDiabetes ketoacidosis
Diabetes ketoacidosisOmkar Singh
 
Complications of Diabetes Mellitus
Complications of Diabetes MellitusComplications of Diabetes Mellitus
Complications of Diabetes MellitusCarmela Domocmat
 
Hypoglycemia for nursing
Hypoglycemia for nursingHypoglycemia for nursing
Hypoglycemia for nursingSafad R. Isam
 
Diabetic ketoacidosis
Diabetic ketoacidosisDiabetic ketoacidosis
Diabetic ketoacidosisPinky Rathee
 

What's hot (20)

Hypoglycemia- Assessment and Treatment
Hypoglycemia- Assessment and TreatmentHypoglycemia- Assessment and Treatment
Hypoglycemia- Assessment and Treatment
 
DKA
DKADKA
DKA
 
Hyperosmolar Hyperglycaemic State
Hyperosmolar Hyperglycaemic StateHyperosmolar Hyperglycaemic State
Hyperosmolar Hyperglycaemic State
 
Management of diabetic ketoacidosis dka
Management of diabetic ketoacidosis dkaManagement of diabetic ketoacidosis dka
Management of diabetic ketoacidosis dka
 
Management of diabetic ketoacidosis
Management of diabetic ketoacidosisManagement of diabetic ketoacidosis
Management of diabetic ketoacidosis
 
Diabetic coma clinical_features
Diabetic coma clinical_features Diabetic coma clinical_features
Diabetic coma clinical_features
 
hypoglycemia
hypoglycemiahypoglycemia
hypoglycemia
 
Hyperosmolar hyperglycaemic state
Hyperosmolar  hyperglycaemic  stateHyperosmolar  hyperglycaemic  state
Hyperosmolar hyperglycaemic state
 
Hyperglycemic hyperosmolar
Hyperglycemic hyperosmolarHyperglycemic hyperosmolar
Hyperglycemic hyperosmolar
 
Hypoglycemia
Hypoglycemia Hypoglycemia
Hypoglycemia
 
Diabetic emergency
Diabetic emergencyDiabetic emergency
Diabetic emergency
 
Hypoglycemia
HypoglycemiaHypoglycemia
Hypoglycemia
 
Status Epilepticus
Status EpilepticusStatus Epilepticus
Status Epilepticus
 
DIABETES MELLITUS and surgeon
DIABETES MELLITUS and surgeonDIABETES MELLITUS and surgeon
DIABETES MELLITUS and surgeon
 
Diabetic ketoacidosis by dr. noman
Diabetic ketoacidosis by dr. nomanDiabetic ketoacidosis by dr. noman
Diabetic ketoacidosis by dr. noman
 
Hyperkalemia 160108171542
Hyperkalemia 160108171542Hyperkalemia 160108171542
Hyperkalemia 160108171542
 
Diabetes ketoacidosis
Diabetes ketoacidosisDiabetes ketoacidosis
Diabetes ketoacidosis
 
Complications of Diabetes Mellitus
Complications of Diabetes MellitusComplications of Diabetes Mellitus
Complications of Diabetes Mellitus
 
Hypoglycemia for nursing
Hypoglycemia for nursingHypoglycemia for nursing
Hypoglycemia for nursing
 
Diabetic ketoacidosis
Diabetic ketoacidosisDiabetic ketoacidosis
Diabetic ketoacidosis
 

Similar to Diabetic emergencies

Determination of Blood Glucose Using Glusose Oxidase-Peroxidase Method
Determination of Blood Glucose Using Glusose Oxidase-Peroxidase MethodDetermination of Blood Glucose Using Glusose Oxidase-Peroxidase Method
Determination of Blood Glucose Using Glusose Oxidase-Peroxidase MethodZoldylck
 
Anesthesia considration for DIABETES MELLITUS
Anesthesia considration for DIABETES MELLITUSAnesthesia considration for DIABETES MELLITUS
Anesthesia considration for DIABETES MELLITUSibrahimelkathiri1
 
hypoglycemia-ab-161021110937.pdf
hypoglycemia-ab-161021110937.pdfhypoglycemia-ab-161021110937.pdf
hypoglycemia-ab-161021110937.pdfTharwaShqairat
 
Alpha-amylase inhibitors: alternative approach for the treatment of type 2 di...
Alpha-amylase inhibitors: alternative approach for the treatment of type 2 di...Alpha-amylase inhibitors: alternative approach for the treatment of type 2 di...
Alpha-amylase inhibitors: alternative approach for the treatment of type 2 di...RajdeepaKundu
 
DIABETES at a glance.pptx
DIABETES at a glance.pptxDIABETES at a glance.pptx
DIABETES at a glance.pptxAKENUWAHILDA
 
HYPOGLYCAEMIA.pptx
HYPOGLYCAEMIA.pptxHYPOGLYCAEMIA.pptx
HYPOGLYCAEMIA.pptxImranSalemee
 
Diabetes Mellitus MBC 120.pptx
Diabetes Mellitus MBC 120.pptxDiabetes Mellitus MBC 120.pptx
Diabetes Mellitus MBC 120.pptxchishimbalouis1
 
Endocrine emergencies
Endocrine emergenciesEndocrine emergencies
Endocrine emergenciesDr. Rubz
 
Endocrine emergencies
Endocrine emergenciesEndocrine emergencies
Endocrine emergenciesMohd Hanafi
 
ANAESTHESIA FOR PATIENT WITH DIABETES MELLITUS
ANAESTHESIA FOR PATIENT WITH DIABETES MELLITUSANAESTHESIA FOR PATIENT WITH DIABETES MELLITUS
ANAESTHESIA FOR PATIENT WITH DIABETES MELLITUSshashikantsharma109
 
Daibetes Mellitus .ppt
Daibetes Mellitus .pptDaibetes Mellitus .ppt
Daibetes Mellitus .pptAmanKarn5
 
Complications of diabetes melitus
Complications of diabetes melitusComplications of diabetes melitus
Complications of diabetes melitusANILKUMAR BR
 
clinical biochemistry diabetes mellitus
clinical biochemistry diabetes  mellitusclinical biochemistry diabetes  mellitus
clinical biochemistry diabetes mellitusMihrabanMira
 
Metabolic-Emergencies.pptx
Metabolic-Emergencies.pptxMetabolic-Emergencies.pptx
Metabolic-Emergencies.pptxWengelRedkiss
 
Metabolic emergencies in diabetes mellitus
Metabolic emergencies in diabetes mellitusMetabolic emergencies in diabetes mellitus
Metabolic emergencies in diabetes mellitusNikhil Chougule
 
Revise Family Case Presentation Final
Revise Family Case Presentation   FinalRevise Family Case Presentation   Final
Revise Family Case Presentation Finalliza mariposque
 
Endocrine Emergencies.pptx
Endocrine Emergencies.pptxEndocrine Emergencies.pptx
Endocrine Emergencies.pptxmunriz
 

Similar to Diabetic emergencies (20)

Determination of Blood Glucose Using Glusose Oxidase-Peroxidase Method
Determination of Blood Glucose Using Glusose Oxidase-Peroxidase MethodDetermination of Blood Glucose Using Glusose Oxidase-Peroxidase Method
Determination of Blood Glucose Using Glusose Oxidase-Peroxidase Method
 
Anesthesia considration for DIABETES MELLITUS
Anesthesia considration for DIABETES MELLITUSAnesthesia considration for DIABETES MELLITUS
Anesthesia considration for DIABETES MELLITUS
 
hypoglycemia-ab-161021110937.pdf
hypoglycemia-ab-161021110937.pdfhypoglycemia-ab-161021110937.pdf
hypoglycemia-ab-161021110937.pdf
 
Alpha-amylase inhibitors: alternative approach for the treatment of type 2 di...
Alpha-amylase inhibitors: alternative approach for the treatment of type 2 di...Alpha-amylase inhibitors: alternative approach for the treatment of type 2 di...
Alpha-amylase inhibitors: alternative approach for the treatment of type 2 di...
 
CS18.hpeace
CS18.hpeaceCS18.hpeace
CS18.hpeace
 
DIABETES at a glance.pptx
DIABETES at a glance.pptxDIABETES at a glance.pptx
DIABETES at a glance.pptx
 
HYPOGLYCAEMIA.pptx
HYPOGLYCAEMIA.pptxHYPOGLYCAEMIA.pptx
HYPOGLYCAEMIA.pptx
 
Diabetes Mellitus MBC 120.pptx
Diabetes Mellitus MBC 120.pptxDiabetes Mellitus MBC 120.pptx
Diabetes Mellitus MBC 120.pptx
 
Endocrine emergencies
Endocrine emergenciesEndocrine emergencies
Endocrine emergencies
 
Endocrine emergencies
Endocrine emergenciesEndocrine emergencies
Endocrine emergencies
 
Diabetes Mellitus
Diabetes MellitusDiabetes Mellitus
Diabetes Mellitus
 
ANAESTHESIA FOR PATIENT WITH DIABETES MELLITUS
ANAESTHESIA FOR PATIENT WITH DIABETES MELLITUSANAESTHESIA FOR PATIENT WITH DIABETES MELLITUS
ANAESTHESIA FOR PATIENT WITH DIABETES MELLITUS
 
Daibetes Mellitus .ppt
Daibetes Mellitus .pptDaibetes Mellitus .ppt
Daibetes Mellitus .ppt
 
Complications of diabetes melitus
Complications of diabetes melitusComplications of diabetes melitus
Complications of diabetes melitus
 
clinical biochemistry diabetes mellitus
clinical biochemistry diabetes  mellitusclinical biochemistry diabetes  mellitus
clinical biochemistry diabetes mellitus
 
Metabolic-Emergencies.pptx
Metabolic-Emergencies.pptxMetabolic-Emergencies.pptx
Metabolic-Emergencies.pptx
 
Metabolic emergencies in diabetes mellitus
Metabolic emergencies in diabetes mellitusMetabolic emergencies in diabetes mellitus
Metabolic emergencies in diabetes mellitus
 
Diabetes mellitus
Diabetes mellitusDiabetes mellitus
Diabetes mellitus
 
Revise Family Case Presentation Final
Revise Family Case Presentation   FinalRevise Family Case Presentation   Final
Revise Family Case Presentation Final
 
Endocrine Emergencies.pptx
Endocrine Emergencies.pptxEndocrine Emergencies.pptx
Endocrine Emergencies.pptx
 

More from bajah423

High Blood Pressure
High Blood PressureHigh Blood Pressure
High Blood Pressurebajah423
 
Chronic Kidney Disease
Chronic Kidney DiseaseChronic Kidney Disease
Chronic Kidney Diseasebajah423
 
UTI in Pregnancy
UTI in PregnancyUTI in Pregnancy
UTI in Pregnancybajah423
 
EKG 12 Leads
EKG 12 LeadsEKG 12 Leads
EKG 12 Leadsbajah423
 
Insulin Therapy in Pregnant Women
Insulin Therapy in Pregnant WomenInsulin Therapy in Pregnant Women
Insulin Therapy in Pregnant Womenbajah423
 
Dyspnea and Pulmonary Edema
Dyspnea and Pulmonary EdemaDyspnea and Pulmonary Edema
Dyspnea and Pulmonary Edemabajah423
 

More from bajah423 (7)

High Blood Pressure
High Blood PressureHigh Blood Pressure
High Blood Pressure
 
Chronic Kidney Disease
Chronic Kidney DiseaseChronic Kidney Disease
Chronic Kidney Disease
 
UTI in Pregnancy
UTI in PregnancyUTI in Pregnancy
UTI in Pregnancy
 
DM Drugs
DM DrugsDM Drugs
DM Drugs
 
EKG 12 Leads
EKG 12 LeadsEKG 12 Leads
EKG 12 Leads
 
Insulin Therapy in Pregnant Women
Insulin Therapy in Pregnant WomenInsulin Therapy in Pregnant Women
Insulin Therapy in Pregnant Women
 
Dyspnea and Pulmonary Edema
Dyspnea and Pulmonary EdemaDyspnea and Pulmonary Edema
Dyspnea and Pulmonary Edema
 

Recently uploaded

EPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptxEPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptxRaymartEstabillo3
 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTiammrhaywood
 
Hierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of managementHierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of managementmkooblal
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Educationpboyjonauth
 
Meghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media ComponentMeghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media ComponentInMediaRes1
 
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdfFraming an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdfUjwalaBharambe
 
Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatYousafMalik24
 
internship ppt on smartinternz platform as salesforce developer
internship ppt on smartinternz platform as salesforce developerinternship ppt on smartinternz platform as salesforce developer
internship ppt on smartinternz platform as salesforce developerunnathinaik
 
CELL CYCLE Division Science 8 quarter IV.pptx
CELL CYCLE Division Science 8 quarter IV.pptxCELL CYCLE Division Science 8 quarter IV.pptx
CELL CYCLE Division Science 8 quarter IV.pptxJiesonDelaCerna
 
MARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized GroupMARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized GroupJonathanParaisoCruz
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxpboyjonauth
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)eniolaolutunde
 
Pharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdfPharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdfMahmoud M. Sallam
 
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxiammrhaywood
 
Final demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptxFinal demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptxAvyJaneVismanos
 
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Celine George
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxmanuelaromero2013
 

Recently uploaded (20)

EPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptxEPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptx
 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
 
Hierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of managementHierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of management
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Education
 
9953330565 Low Rate Call Girls In Rohini Delhi NCR
9953330565 Low Rate Call Girls In Rohini  Delhi NCR9953330565 Low Rate Call Girls In Rohini  Delhi NCR
9953330565 Low Rate Call Girls In Rohini Delhi NCR
 
Meghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media ComponentMeghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media Component
 
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdfFraming an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
 
Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice great
 
internship ppt on smartinternz platform as salesforce developer
internship ppt on smartinternz platform as salesforce developerinternship ppt on smartinternz platform as salesforce developer
internship ppt on smartinternz platform as salesforce developer
 
CELL CYCLE Division Science 8 quarter IV.pptx
CELL CYCLE Division Science 8 quarter IV.pptxCELL CYCLE Division Science 8 quarter IV.pptx
CELL CYCLE Division Science 8 quarter IV.pptx
 
MARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized GroupMARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized Group
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptx
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)
 
Pharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdfPharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdf
 
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
 
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
 
Final demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptxFinal demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptx
 
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptx
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 

Diabetic emergencies

  • 2. Objectives General Objective: • Identify the common diabetic complications in an emergency setting. Specific Objective: • Describe diabetic ketoacidosis, hyperosmolar syndrome, and hypoglycemia. • Describe their diagnosis, treatment, and prevention.
  • 3. Introduction • People with diabetes suffer from diabetic complications that may arise due to erratic blood sugar levels, missed meals, accidental overdose of medications, or too much strenuous exercise. These things could affect the sensitive body of a person with diabetes and could lead to serious incidences of hypoglycemia or hyperglycemia.
  • 4. Introduction • Uncontrolled blood sugar often contributes to the incidence of diabetic emergencies and complications. Individuals who experience blood sugar levels that are too high or low for prolonged periods of time may develop conditions that could lead to a coma. • Hypoglycemia results from excessively low blood sugar levels caused by either insufficient food consumption or the presence of too much insulin.
  • 5. Introduction • Diabetic ketoacidosis is a condition that occurs due to an absence or insufficient supply of insulin, which forces the body to burn fat and creates ketones that subsequently accumulate in the body. • Hyperosmolar syndrome is a diabetic condition that results from excessively high blood sugar levels, which cause the blood to adopt a thick consistency.
  • 7. • Hypoglycemia or low blood glucose is a clinical state associated with <55mg/dl or low plasma glucose with typical symptoms. The Journal of Clinical Endocrinology & Metabolism March 1, 2009 vol. 94 no. 3 709-
  • 8. Whipples triad  Symptoms consistent with hypoglycemia  Low plasma glucose concentration  Relief of those symptoms after the plasma glucose level is raised The Journal of Clinical Endocrinology & Metabolism March 1, 2009 vol. 94 no. 3 709-
  • 9. Physiological responses The Journal of Clinical Endocrinology & Metabolism March
  • 10. Risk factors  insulin doses are excessive, ill-timed, or of the wrong type  influx of exogenous glucose   insulin-independent glucose utilization   sensitivity to insulin   endogenous glucose production   insulin clearance  The Journal of Clinical Endocrinology & Metabolism March 1, 2009 vol. 94 no. 3 709-
  • 11. Clinical features MILD HYPOGLYCEMIA - mainly adrenergic or cholinergic symptoms  Pallor  Diaphoresis  Tachycardia  Palpitations  Hunger  Paresthesias The Journal of Clinical Endocrinology & Metabolism March 1, 2009 vol. 94 no. 3 709-
  • 12. Clinical features MODERATE HYPOGLYCEMIA (<40 mg/dL) - mainly neuroglycopenic symptoms  Inability to concentrate  Confusion  Slurred speech  Irrational behaviour  Slower reaction time  Blurred vision  Somnolence  Extreme fatigue The Journal of Clinical Endocrinology & Metabolism March 1, 2009 vol. 94 no. 3 709-
  • 13. Clinical features SEVERE HYPOGLYCEMIA (<20 mg/dL )  Associated with severe impairment of neurologic function  Completely disoriented behavior  LOC  Coma  Seizures The Journal of Clinical Endocrinology & Metabolism March 1, 2009 vol. 94 no. 3 709-
  • 14. Treatment MILD HYPOGLYCEMIA  Oral carbohydrates (at least 15gm)  Sources include • Three glucose tablets (5g each) • 2 ½ cups of fruit juice • ½ to ¾ cup regular soda • 1 cup of milk  If patient is unable to take orallyThe Journal of Clinical give IV dextrose Endocrinology & Metabolism March 1, 2009 vol. 94 no. 3 709-
  • 15. Treatment MODERATE TO SEVERE HYPOGLYCEMIA  Dextrose - 50mL of 50% dextrose IV bolus after blood draw followed by 10% dextrose  Glucagon – 1mg IM or SC can be given  Effective in treating hypoglycemia only if sufficient liver glycogen present  These measures raise blood glucose only transiently  Patient is urged to eat as soon as possible The Journal of Clinical Endocrinology & Metabolism March 1, 2009 vol. 94 no. 3 709-
  • 16. Prevention  Patient education  Knowing signs and symptoms of hypoglycemia  Take meals on a regular schedule  Carry a source of carbohydrate  Self monitoring of blood glucose  Take regular insulin at least 30 min before eating The Journal of Clinical Endocrinology & Metabolism March 1, 2009 vol. 94 no. 3 709-
  • 18.  Acute, major, life-threatening complication of diabetes  Increase in the serum concentration of ketones  Blood glucose level of greater than 250 mg/dL  Blood pH of less than 7.2  Bicarbonate level of 18 mEq/L or less Joint British Diabetes Society guideline for the management of diabetic ketoacidosis Diabetic Medicine Volume 28, Issue 5, pages 508–515, May
  • 19.  Incidence about 1 out of 2000  Usually occurs in younger individuals but can occur in patients with diabetes at any age  Mortality rates are around 2-5%  No sex predilection Joint British Diabetes Society guideline for the management of diabetic ketoacidosis Diabetic Medicine Volume 28, Issue 5, pages 508–515, May
  • 20. Mechanism  Absolute or relative insulin deficiency  Increased gluconeogenesis  Elevation of counter regulatory hormones such as glucagon, cortisol, growth hormone, and catecholamines Joint British Diabetes Society guideline for the management of diabetic ketoacidosis Diabetic Medicine Volume 28, Issue 5, pages 508–515, May
  • 21. Causes • Infections • Inadequate insulin treatment or non-compliance • New onset diabetes • Infarction • Drugs • Pregnancy Joint British Diabetes Society guideline for the management of diabetic ketoacidosis Diabetic Medicine Volume 28, Issue 5, pages 508–515, May
  • 22. Classification Moderate Mild DKA Severe DKA DKA Plasma glucose > 250 mg/dl > 250 mg/dl > 250 mg/dl Arterial ph 7.25-7.30 7.0-7.24 < 7.0 Serum 15-18 10-<15 < 10 bicarbonate Urine ketones + + + Anion gap >10 >12 >12 Alteration in Joint British Diabetes Society guideline for the alert Alert/drowsy stupor/coma sensorium management of diabetic ketoacidosis Diabetic Medicine Volume 28, Issue 5, pages 508–515, May
  • 23. Clinical presentations • Nausea/vomiting  Thirst/polyuria • Abdominal pain  Shortness of breath • Generalized weakness  Malaise/lethargy • Confusional state • Fever, dysuria, coughing • Chest pain • Palpitations Joint British Diabetes Society guideline for the management of diabetic ketoacidosis Diabetic Medicine Volume 28, Issue 5, pages 508–515, May
  • 24. Physical findings  Tachycardia  Signs of dehydration - weak and rapid pulse, dry tongue and skin, hypotension, and increased capillary refill time  Tachypnea/ respiratory distress  Acetone odor in breath  Abdominal tenderness  Lethargy/ obtundation/ cerebral edema/ possibly coma Joint British Diabetes Society guideline for the management of diabetic ketoacidosis Diabetic  Fever/ Hypothermia 28, Issue 5, pages 508–515, May Medicine Volume
  • 25. Laboratory findings  Hyperglycemia >250mg/dL  Serum ketones +  ABG:  metabolic acidosis  low bicarbonate  low pH (<7.2) Joint British Diabetes Society guideline for the management of diabetic ketoacidosis Diabetic Medicine Volume 28, Issue 5, pages 508–515, May
  • 26. Serum electrolytes • Serum potassium may be mildly elevated despite total body potassium deficit • The serum sodium level usually is low (1.6meq reduction in serum sodium for each 5.6mmol/L or 100mg/dL of rise in serum glucose) • The serum chloride and phosphorus levels are low  The anion gap is elevated  Plasma osmolarity usually is increased (>290 mOsm/L).Joint British Diabetes Society guideline for the management of diabetic ketoacidosis Diabetic Medicine Volume 28, Issue 5, pages 508–515, May
  • 27. Others  Leukocytosis (even without infection)  BUN and creatinine are frequently increased  Hypertriglyceridemia/ Hyperlipoproteinemia  Serum assays for β hydroxybutrate more accurately reflects the true ketone body level • ECG – for detection of hypokalemia/ hyperkalemia, myocardial infarction (silent MI in diabetics) Joint British Diabetes Society guideline for the management of diabetic ketoacidosis Diabetic Medicine Volume 28, Issue 5, pages 508–515, May
  • 28. Differential diagnosis LACTIC ACIDOSIS  most common cause of metabolic acidosis in hospitalized patients  presentation is identical to DKA  serum glucose and ketones should be normal  serum lactate concentration should be greater than 5mm  therapy is directed at the underlying cause and optimizing tissue perfusion Society guideline for the Joint British Diabetes management of diabetic ketoacidosis Diabetic Medicine Volume 28, Issue 5, pages 508–515, May
  • 29. Differential diagnosis STARVATION KETOSIS  due to inadequate carbohydrate availability, resulting in lipolysis and ketone production  blood glucose is usually normal  blood rarely does have large amounts of ketones  arterial pH is normal  anion gap is at most mildly elevated Joint British Diabetes Society guideline for the management of diabetic ketoacidosis Diabetic Medicine Volume 28, Issue 5, pages 508–515, May
  • 30. Differential diagnosis ALCOHOLIC KETOACIDOSIS • anion gap is elevated • serum and urine ketones are present • alcoholic ketoacidosis produces an even higher ratio of β-hydroxybutyrate to acetoacetate than DKA does • usually, patient is normoglycemic or hypoglycemic Joint British Diabetes Society guideline for the management of diabetic ketoacidosis Diabetic Medicine Volume 28, Issue 5, pages 508–515, May
  • 31. Differential diagnosis UREMIC ACIDOSIS  Extremely large elevations in the BUN (>200 mg/dL) and creatinine (>10 mg/dL) with normoglycemia  pH and anion gap are usually only mildly abnormal  treatment is supportive, with careful attention to fluid and electrolytes until dialysis can be performed Joint British Diabetes Society guideline for the management of diabetic ketoacidosis Diabetic Medicine Volume 28, Issue 5, pages 508–515, May
  • 32. Treatment IV FLUIDS • 2-3L of 0.9% saline over first 1–3 h (10–15mL/kg per hour) • 0.45% saline at 150-300mL/h (if hemodynamically stable and urine output is adequate ) • change to 5% glucose and 0.45% saline at 100–200 mL/h when plasma glucose reaches 250mg/dL (14mmol/L). Joint British Diabetes Society guideline for the management of diabetic ketoacidosis Diabetic Medicine Volume 28, Issue 5, pages 508–515, May
  • 33. Treatment INSULIN • if serum K+ is <3.3mmol/L, do not administer insulin until it is corrected to >3.3mmol/L • bolus of IV (0.1 units/kg) or IM (0.3 units/kg) short- acting insulin followed by 0.1 units/kg/hr by continuous IV infusion • Increase 2- to 3-fold if no response by 2–4h Joint British Diabetes Society guideline for the management of diabetic ketoacidosis Diabetic Medicine Volume 28, Issue 5, pages 508–515, May
  • 34. Treatment INSULIN • IV regular insulin should be given until the acidosis resolves and the patient is metabolically stable • Intermediate or long-acting insulin, in combination with SC short-acting insulin, should be administered as soon as the patient resumes eating Joint British Diabetes Society guideline for the management of diabetic ketoacidosis Diabetic Medicine Volume 28, Issue 5, pages 508–515, May
  • 35. Treatment MONITOR  Blood glucose every 1–2 h;  Serum electrolytes and anion gap every 4 h for first 24 h.  Blood pressure, pulse, respirations, mental status, fluid intake and output every 1–4 h. Joint British Diabetes Society guideline for the management of diabetic ketoacidosis Diabetic Medicine Volume 28, Issue 5, pages 508–515, May
  • 37.  The condition is characterized by • Hyperglycemia • Hyperosmolarity • Dehydration without significant ketoacidosis 10.2337/diacare.27.2007.S94 Diabetes Care January 2004vol. 27 no. suppl 1 s94- s102
  • 38.  Incidence is 1.7 case per 10000  Mortality rate is high (10-20%) and usually due to a co-morbid illness  (HHS) has a mean age of onset early in the seventh decade 10.2337/diacare.27.2007.S94 Diabetes Care January 2004vol. 27 no. suppl 1 s94- s102
  • 39. Pathophysiology  Relative insulin deficiency and inadequate fluid intake  Insulin deficiency increases hepatic glucose production (through glycogenolysis and gluconeogenesis) and impairs glucose utilization in skeletal muscle  Hyperglycemia induces an osmotic diuresis that leads to intravascular volume depletion, which is exacerbated by inadequate fluid replacement 10.2337/diacare.27.2007.S94  Lower levels of counterregulatory hormones and free Diabetes Care January 2004vol. 27 no. suppl 1 s94- fatty acids have been found in HHS than in DKA s102
  • 40. Clinical features HISTORY  Usually elderly individual, type 2 DM  Mental confusion, lethargy, and coma  Absence of nausea, vomiting, abdominal pain  Frequent precipitants – pneumonia, sepsis, stroke MI, etc., 10.2337/diacare.27.2007.S94 Diabetes Care January 2004vol. 27 no. suppl 1 s94- s102
  • 41. vs DKA 10.2337/diacare.27.2007.S94 Diabetes Care January 2004vol. 27 no. suppl 1 s94- s102
  • 42. Treatment IV FLUIDS  1–3L of 0.9% normal saline over the first 2–3 h. If the serum sodium >150 meq/L, 0.45% saline should be used.  After hemodynamic stability is achieved, the IV fluid administration is directed at reversing the free water deficit using hypotonic fluids (0.45% saline initially then D5W).  The calculated free water deficit (which averages 9– 10.2337/diacare.27.2007.S94 10L) should be reversed over the next 1–2 days Diabetes Care January 2004vol. 27 no. suppl 1 s94- (infusion rates of 200–300 mL/h of hypotonic s102
  • 43. Treatment INSULIN • IV insulin bolus of 0.1units/kg followed by IV insulin at a constant infusion rate of 0.1units/kg per hour. • If the serum glucose does not fall, increase the insulin infusion rate by twofold • Glucose should be added to IV fluid when the plasma glucose falls to 250 mg/dL, and the insulin infusion rate should be decreased to 0.05– 0.1units/kg per hour. 10.2337/diacare.27.2007.S94 Diabetes Care January 2004vol. 27 no. suppl 1 s94- s102
  • 44. Treatment INSULIN  The insulin infusion should be continued until the patient has resumed eating and can be transferred to a SC insulin regimen  To avoid cerebral edema the blood glucose level should be maintained between 250-300mg/dl until hyperosmolarity and mental status improve and the patient becomes clinically stable 10.2337/diacare.27.2007.S94 Diabetes Care January 2004vol. 27 no. suppl 1 s94- s102
  • 45. Treatment POTASSIUM REPLETION  ECG monitoring for hyperkalemia or hypokalemia  If K+ < 5.5 give 10-20mEq/hr  If K+ < 3.5 give 40-80mEq/hr  Administer half as chloride and half as phosphate salts 10.2337/diacare.27.2007.S94 Diabetes Care January 2004vol. 27 no. suppl 1 s94- s102
  • 46. Monitoring  EKG  Vital signs  1-2 hourly glucose  Serum electrolytes: 2-6 hourly  BUN and creatinine: 6-24 hourly  Ketones: 6-24 hourly 10.2337/diacare.27.2007.S94 Diabetes Care January 2004vol. 27 no. suppl 1 s94- s102
  • 47. Pathogenesis of DKA and HHS: stress, infection, or insufficient insulin. FFA, free fatty acid
  • 48. Conclusion • Diabetic emergencies are common in patients with diabetes, and the effects can be devastating. However, with continued emphasis on the timely and appropriate identification and management of diabetic emergencies, hopefully this may change. • It is therefore important for those with diabetes to keep their sugar levels normal to prevent complications and to be able to live normal, healthy lives.

Editor's Notes

  1. The universal symbol for diabetes.The purpose of the diabetes symbol is to give diabetes a common identity.Until 2006, there was no global symbol for diabetes. It aims to:support all existing efforts to raise awareness about diabetesinspire new activities, bring diabetes to the attention of the general publicbrand diabetesprovide a means to show support for the fight against diabetes
  2. Insulin doses are excessive, ill-timed, or of the wrong type influx of exogenous glucose (overnight fast or following missed meals or snacks)↑ insulin-independent glucose utilization (e.g., during exercise)↑ sensitivity to insulin (e.g., with improved glycemic control, in the middle of the night, late after exercise, or with increased fitness or weight loss)  endogenous glucose production (e.g., following alcohol ingestion) insulin clearance (e.g., in renal failure).
  3. Infections – pneumonia, UTI, sepsis, gastroenteritis etc.Inadequate insulin treatment or non-complianceNew onset diabetesInfarction - Myocardial infarction, cerebral, mesenteric, peripheralDrugs – cocaine, atypical antipsychotics, corticosteroids, glucagon, interferon etc.,Pregnancy
  4. The anion gap is elevated ([Na + K] - [Cl + HCO3] &gt;13 mEq/L).Plasma osmolarity usually is increased (&gt;290 mOsm/L). If plasma osmolarity cannot be directly measured, it may be calculated as followsPlasma osmolarity = 2 (Na + K) + BUN/3 + glucose/18.